(Q51474050)

5 April 2018

title

Silencing pancreatic adenocarcinoma upregulated factor (PAUF) increases the sensitivity of pancreatic cancer cells to gemcitabine. (English)

1 reference

5 April 2018

pancreatic adenocarcinoma

1 reference

1 reference

Chong-Chong Gao

1

1 reference

5 April 2018

Xiao-Lan Xu

2

1 reference

5 April 2018

Fei Li

3

1 reference

5 April 2018

Ben-Gang Gong

4

1 reference

5 April 2018

Shuang Liu

5

1 reference

5 April 2018

Ye-Qing Cui

6

1 reference

5 April 2018

Hai-Chen Sun

7

1 reference

5 April 2018

Ping-Yong Xu

8

1 reference

5 April 2018

Ya-Min Zheng

9

1 reference

5 April 2018

Hua Jiang

10

1 reference

5 April 2018

publication date

18 December 2015

1 reference

5 April 2018

published in

Tumor Biology

1 reference

5 April 2018

volume

37

1 reference

5 April 2018

issue

6

1 reference

5 April 2018

page(s)

7555-7564

1 reference

5 April 2018

https://scigraph.springernature.com/pub.10.1007/s13277-015-4641-2

exact match

0 references

cites work

Cancer statistics, 2010

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: a phase III trial of the National Cancer Institute of Canada Clinical Trials Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Pancreatic cancer: understanding and overcoming chemoresistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Pancreatic adenocarcinoma up-regulated factor (PAUF), a novel up-regulated secretory protein in pancreatic ductal adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Pancreatic adenocarcinoma up-regulated factor expression is associated with disease-specific survival in cervical cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

PAUF functions in the metastasis of human pancreatic cancer cells and upregulates CXCR4 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Pancreatic adenocarcinoma up-regulated factor (PAUF) enhances the expression of β-catenin, leading to a rapid proliferation of pancreatic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

PAUF promotes adhesiveness of pancreatic cancer cells by modulating focal adhesion kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Pancreatic adenocarcinoma upregulated factor, a novel endothelial activator, promotes angiogenesis and vascular permeability

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

CXCL12-CXCR4 signalling axis confers gemcitabine resistance to pancreatic cancer cells: a novel target for therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

A PAUF-neutralizing antibody targets both carcinoma and endothelial cells to impede pancreatic tumor progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

NF-kappaB transcription factor induces drug resistance through MDR1 expression in cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

MiR-223 modulates multidrug resistance via downregulation of ABCB1 in hepatocellular carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Expression of P-glycoprotein and multidrug resistance-associated protein is associated with multidrug resistance in gastric cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Xenobiotic, bile acid, and cholesterol transporters: function and regulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

RETRACTED: 3,3'-Diindolylmethane enhances chemosensitivity of multiple chemotherapeutic agents in pancreatic cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

The AKT inhibitor MK-2206 is cytotoxic in hepatocarcinoma cells displaying hyperphosphorylated AKT-1 and synergizes with conventional chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

Inhibition of AKT2 enhances sensitivity to gemcitabine via regulating PUMA and NF-κB signaling pathway in human pancreatic ductal adenocarcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-015-4641-2

MicroRNA-29a induces resistance to gemcitabine through the Wnt/β-catenin signaling pathway in pancreatic cancer cells

21 January 2018

1 reference

12 December 2020

Silencing of pancreatic adenocarcinoma upregulated factor by RNA interference inhibits the malignant phenotypes of human colorectal cancer cells

1 reference

12 December 2020

Ursolic acid inhibits growth and induces apoptosis in gemcitabine-resistant human pancreatic cancer via the JNK and PI3K/Akt/NF-κB pathways

1 reference

12 December 2020

Association of pancreatic adenocarcinoma up-regulated factor expression in ovarian mucinous adenocarcinoma with poor prognosis

1 reference

12 December 2020

Phosphatidylinositol 3-kinase as a mediator of TNF-induced NF-kappa B activation

1 reference

12 December 2020

Expression and localization of human multidrug resistance protein (ABCC) family members in pancreatic carcinoma

1 reference

12 December 2020

10.1007/S13277-015-4641-2

Identifiers

DOI

1 reference

5 April 2018

1 reference

5 April 2018